Continuous positive airway pressure (CPAP) is the most widely used treatment for obstructive sleep apnea (OSA), and was established four decades ago. An alternative option is to use bilevel ventilation, in order to improve compliance to treatment especially in patients who need a high therapeutic pressure to prevent nocturnal respiratory events. Automatic CPAP or bilevel ventilation are also established among OSA therapeutic choices, and are generally indicated in cases of highly variable therapeutic pressure. The major advances in the field regard OSAS in the context of uncomplicated obesity hypoventilation syndrome (OHS), in which either CPAP or bilevel ventilation yield comparable results, and the increasingly popular use of telemedicine in OSA management. The COVID-19 pandemic has been a major determinant of the shift from traditional clinic-based management to using telemedicine whenever possible. In addition, availability of CPAP data recorded in millions of patients has allowed big-data studies on adherence to CPAP or bilevel ventilation over prolonged periods of time. It can be foreseen that e-Health programs will soon be used for most of the clinical activities in the OSA field.

Bonsignore MR (2021). Advances in ventilatory treatment for OSAS. In F. Lo Russo, S. Gallina (a cura di), Advances in Sleep Apnea (pp. 161-174). New York : Nova Sience Publishers, Inc..

Advances in ventilatory treatment for OSAS

Bonsignore MR
Primo
2021-01-01

Abstract

Continuous positive airway pressure (CPAP) is the most widely used treatment for obstructive sleep apnea (OSA), and was established four decades ago. An alternative option is to use bilevel ventilation, in order to improve compliance to treatment especially in patients who need a high therapeutic pressure to prevent nocturnal respiratory events. Automatic CPAP or bilevel ventilation are also established among OSA therapeutic choices, and are generally indicated in cases of highly variable therapeutic pressure. The major advances in the field regard OSAS in the context of uncomplicated obesity hypoventilation syndrome (OHS), in which either CPAP or bilevel ventilation yield comparable results, and the increasingly popular use of telemedicine in OSA management. The COVID-19 pandemic has been a major determinant of the shift from traditional clinic-based management to using telemedicine whenever possible. In addition, availability of CPAP data recorded in millions of patients has allowed big-data studies on adherence to CPAP or bilevel ventilation over prolonged periods of time. It can be foreseen that e-Health programs will soon be used for most of the clinical activities in the OSA field.
2021
Settore MED/10 - Malattie Dell'Apparato Respiratorio
Bonsignore MR (2021). Advances in ventilatory treatment for OSAS. In F. Lo Russo, S. Gallina (a cura di), Advances in Sleep Apnea (pp. 161-174). New York : Nova Sience Publishers, Inc..
File in questo prodotto:
File Dimensione Formato  
Libro LoRusso-Gallina2021.pdf

Solo gestori archvio

Descrizione: Capitolo
Tipologia: Versione Editoriale
Dimensione 5.88 MB
Formato Adobe PDF
5.88 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/522217
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact